This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board meeting on November 5 to approve September 2026 results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.1 pts less than Nifty Microcap 250 and 1.9 pts less than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
No consolidated or standalone financial figures are provided in this notice. The Board will meet on 5 November 2026 to approve unaudited quarterly and half-year results for the period ended 30 September 2026, along with a limited review report. Trading has been closed since 1 October and will reopen 48 hours after the results are declared.
Only the results date is announced; no figures are provided. Shareholders should wait for the published results before assessing earnings or risks.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹12.45 Cr | ₹10.01 Cr | +24.4% |
| Operating profit | ₹1.63 Cr | ₹0.38 Cr | +324.7% |
| Profit after tax | ₹1.15 Cr | −₹0.12 Cr | turned positive |
| EBITDA margin | 22.9% | 11.5% | +11.3 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.